Literature DB >> 8661133

Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors.

J A Williamson1, J M Bosher, A Skinner, D Sheer, T Williams, H C Hurst.   

Abstract

The AP-2 transcription factor has been shown to play an important role in the development of tissues of ectodermal origin and has also been implicated in mammary oncogenesis. It has recently been found that AP-2 is encoded by a family of related genes, AP-2alpha, AP-2beta, and AP-2gamma. As a further step in understanding the role each of these genes has in development, we have used fluorescence in situ hybridization to map the chromosomal locations of the mouse and human homologues of the newly isolated AP-2beta and AP-2gamma genes. Tcfap2b and Tcfap2c map to mouse chromosomes 1A2-4 and 2H3-4, respectively, while TFAP2B and TFAP2C map to human chromosomes 6p12 and 20q13.2, the latter being a region that is frequently amplified in breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661133     DOI: 10.1006/geno.1996.0351

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  24 in total

1.  Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation.

Authors:  F Zhao; C G Weismann; M Satoda; M E Pierpont; E Sweeney; E M Thompson; B D Gelb
Journal:  Am J Hum Genet       Date:  2001-08-14       Impact factor: 11.025

2.  Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta.

Authors:  M Moser; A Pscherer; C Roth; J Becker; G Mücher; K Zerres; C Dixkens; J Weis; L Guay-Woodford; R Buettner; R Fässler
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

3.  Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.

Authors:  O Nyormoi; Z Wang; D Doan; M Ruiz; D McConkey; M Bar-Eli
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  Involvement of AP-2 in regulation of the R-FABP gene in the developing chick retina.

Authors:  D A Bisgrove; E A Monckton; R Godbout
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

5.  A brother and sister with breast cancer, BRCA2 mutations and bilateral supernumerary nipples.

Authors:  Michael McKay; Ryan Coad
Journal:  Ann Transl Med       Date:  2017-03

6.  Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line.

Authors:  W W Kuang; D A Thompson; R V Hoch; R J Weigel
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

7.  TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation.

Authors:  J Kang; W Kim; S Lee; D Kwon; J Chun; B Son; E Kim; J-M Lee; H Youn; B Youn
Journal:  Oncogene       Date:  2016-09-05       Impact factor: 9.867

8.  Characterization of the human activator protein-2gamma (AP-2gamma) gene: control of expression by Sp1/Sp3 in breast tumour cells.

Authors:  Mark D Hasleton; J Claire Ibbitt; Helen C Hurst
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

9.  Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.

Authors:  Hong-Seok Park; Weon Seo Park; Jolanta Bondaruk; Noriyoshi Tanaka; Hiroshi Katayama; Sangkyou Lee; Philippe E Spiess; Jordan R Steinberg; Zhi Wang; Ruth L Katz; Colin Dinney; Keren J Elias; Yair Lotan; Rizwan C Naeem; Keith Baggerly; Subrata Sen; H Barton Grossman; Bogdan Czerniak
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 13.506

10.  Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.

Authors:  Verena Thewes; Francesca Orso; Richard Jäger; Dawid Eckert; Sabine Schäfer; Gregor Kirfel; Stephan Garbe; Daniela Taverna; Hubert Schorle
Journal:  BMC Cancer       Date:  2010-05-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.